Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Effect of Tibet Rhodiola Capsule on Hypoxia and Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea: A Pilot Trial
Conditions
Interventions
Tibet Rhodiola Capsule
Placebo oral capsule
Locations
1
China
Beijing Anzhen Hospital, Capital Medical University
Beijing, China
Start Date
June 17, 2017
Primary Completion Date
February 28, 2018
Completion Date
May 30, 2018
Last Updated
July 26, 2017
NCT06430957
NCT07292922
NCT07225686
NCT03307330
NCT07380321
NCT07345312
Lead Sponsor
Shao-Ping Nie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions